BackBrainstorm Cell Therapeutics Overview

Brainstorm Cell Therapeutics Income Tax

Track Brainstorm Cell Therapeutics's income tax ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Income Tax

$0

As of Jun 2026

Annual Income Tax (TTM)

$0

Trailing 12 months ending Jun 2026

Average Income Tax (Comparison Companies)

Loading

Income Tax History

Loading

Income Tax Comparison

Loading

Annual Income Tax Growth Rate (%)

Loading...

Annual Income Tax Growth (Absolute)

Loading...

Brainstorm Cell Therapeutics (BCLI) FAQ

As of the most recent data (June 2026), BCLI shows a income tax of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCLI's income tax is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Brainstorm Cell Therapeutics is outperforming or lagging.

Tracking BCLI's income tax over time shows whether Brainstorm Cell Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this income tax page, Stockcircle has Brainstorm Cell Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect income tax (currently $0) with ownership activity and broader fundamentals.

Brainstorm Cell Therapeutics's income tax is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.